Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Elvira Umyarova

Clinical trials sponsored by Elvira Umyarova, explained in plain language.

Supercharged immune cells take on Hard-to-Treat myeloma

Disease control Completed

This early-phase study tests a new treatment for multiple myeloma that has returned or stopped responding to prior therapies. It combines specially engineered natural killer (NK) cells (called TiNK) with an antibody drug (isatuximab) and standard chemotherapy. The main goal is to…

Phase 1 • Sponsor: Elvira Umyarova • Aim: Disease control

Last updated Jul 03, 2026 00:00 UTC